ID
19113
Description
NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Pharmacogenetic and Pharmacogenomic Research.
Keywords
Versions (2)
- 10/4/16 10/4/16 -
- 12/5/16 12/5/16 -
Uploaded on
December 5, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research NCT00334568/ GSK-AVA100193
NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research
Description
PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research
Alias
- UMLS CUI-1
- C0013216
Description
Informed Consent
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
Date informed consent
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0021430
Description
Reason for not obtaining informed consent
Data type
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0566251
Description
Reason Informed Consent Obtained Specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0566251
- UMLS CUI [1,3]
- C2348235
Description
Blood sample collection (DNA)
Alias
- UMLS CUI-1
- C0005834
Description
Has a blood sample been collected for PGx-pharmacogenetic research?
Data type
boolean
Alias
- UMLS CUI [1]
- C0005834
Description
Date sample taken
Data type
date
Alias
- UMLS CUI [1]
- C1302413
Description
Withdrawal of consent
Alias
- UMLS CUI-1
- C1707492
Description
Blood sample Destruction
Alias
- UMLS CUI-1
- C1948029
- UMLS CUI-2
- C0178913
Description
Request for sample destruction
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
Description
Request for sample destruction reason
Data type
text
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
- UMLS CUI [1,4]
- C0392360
Description
Request for sample destruction other
Data type
text
Alias
- UMLS CUI [1,1]
- C1272683
- UMLS CUI [1,2]
- C1948029
- UMLS CUI [1,3]
- C0178913
- UMLS CUI [1,4]
- C2348235
Similar models
NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Pharmacogenetic and Pharmacogenomic Research
C0021430 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0013216 (UMLS CUI [1,2])
C0178913 (UMLS CUI-2)
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0392360 (UMLS CUI [1,4])
C1948029 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])